Evaluation of the in vitro colistin susceptibility of Pseudomonas aeruginosa and Acinetobacter baumannii strains at a tertiary care centre in Western Turkey;Valutazione della sensibilità in vitro a colistina in Pseudomonas aeruginosa e Acinetobacter baumannii isolati presso un ospedale della Turchia occidentale

Infezioni in Medicina

Volumn 22, Issue 1, 2014, Pages 36-40

  Ece, Gulfem ^a   Samlioglu, Pinar ^b   Atalay, Sabri ^b   Kose, Sukran ^b  

^a IZMIR UNIVERSITY   (Turkey)

^b TEPECIK EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TIGECYCLINE; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NONHUMAN; PSEUDOMONAS AERUGINOSA; TERTIARY CARE CENTER; VERY ELDERLY; DRUG EFFECTS; EVALUATION STUDY; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; TURKEY;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; COLISTIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; TERTIARY CARE CENTERS; TURKEY;

EID: 84897374547     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. http://www.cdc.gov/hicpac/mdro/mdro_2.html
2. Candel F.J., Calvo N., Head J., et al. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects. Rev. Esp. Quimioter. 23, 2, 103-108, 2010.
3. Storm D.R., Rosenthal K.S., Swanson P.E. Polymyxin and related peptide antibiotics. Annu. Rev. Biochem. 46, 723-763, 1977.
4. Yahav D., Farbman L., Leibovici L., et al. Colistin: new lessons on an old antibiotic. Clin. Microbiol. Infect. 18, 1, 18-29, 2012.
5. Michalopoulos A.S., Tsiodras S., Rellos K., et al. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic. Clin. Microbiol. Infect. 11, 2, 115-121, 2005.
6. Falagas M.E., Kasiakou S.K. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin. Infect. Dis., 40,1333-1341, 2005.
7. Akali{dotless}n H. Kolistin [Colistin]. ANKEM Derg. 21, 2, 26-28, 2007.
8. Clinical and Laboratory Standards Institute. Performance standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. M100-S21 January 2011 Vol. 31 No. 1 pages 60-63.
9. Aloush V., Navon-Venezia S., Seigman-Igra Y. et al. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob. Agents. Chemother. 50, 43-48, 2006.
10. Lia J., Nationa R.L., Milneb R.W., et al. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria. Int. J. Antimicrob. Agents. 25, 1, 11-25, 2005.
11. Maalej S.M., Meziou M.R., Rhimi F.M., Hammami A. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae. Lett. Appl. Microbiol. 53, 5, 546-551, 2011.
12. Lo-Ten-Foe J.R., de Smet A.M., Diederen B.M., Kluytmans J.A., van Keulen P.H. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrob. Agents Chemother. 51, 10, 3726-3730, 2007.
13. van der Heijden I.M., Levin A.S., De Pedri E.H., et al. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem resistant P. aeruginosa to polymyxins. Ann. Clin. Microbiol. Antimicrob. 6, 8, 2007.
14. Walkty A., DeCorby M., Nichol K., et al. In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD Study, 2007-2008. Antimicrob. Agents. Chemother. 53, 11, 4924-4926, 2009.
15. Sinirtas M., Akalin H., Gedikoglu S. Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance. Int. J. Infect. Dis. 13, 5, e217-e220, 2009.
16. Somily A.M. Comparison of E-test and disc diffusion methods for the in vitro evaluation of the antimicrobial activity of colistin in multi-drug resistant Gram-negative Bacilli. Saudi Med. J. 31, 5, 507-511, 2010.
17. Lee J.Y., Song J.H., Ko K.S. Identification of Nonclonal Pseudomonas aeruginosa Isolates with Reduced Colistin Susceptibility in Korea. Microb. Drug. Resist. 17, 2, 299-304, 2011.
18. Ozdemir M., Erayman I., Turk Dagi H., et al. Hastane Infeksiyonu etkeni Pseudomonas suslarinin antibiyotiklere duyarliliklarii. [Antibiotic Susceptibility of Pseudomonas Strains from Nosocomial Infections]. ANKEM Derg. 23, 3, 122-126, 2009.
19. Kurt Azap O., Arslan H., Ergin F., et al. Kolistinin non-fermentatif gram-negatif bakterilere in-vitro etkinliginin degerlendirilmesi [In vitro activity of colistin against nonfermentative Gram-negative bacilli]. Ankara Üniversitesi Ti{dotless}p Fakültesi Mecmuasi., 58, 65-67, 2005.
20. Cesur S., Yildiz E., Irmak H., et al. Turkiye'de Yogun Baki{dotless}m Unitelerinden Izole Edilen Pseudomonas aeruginosa Suslarinda Metallo-Beta Laktamaz Enzimlerinin ve Antibiyotik Duyarliliklarinin Karsilastirilmasi. [Metallobeta-Lactamase Enzymes and Antibiotic Susceptibilities in Strains of Pseudomonas aeruginosa Isolated from Intensive Care Units in Turkey]. Turkiye Klinikleri J. Med. Sci. 32, 3, 687-693, 2012.